Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
Report Content
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
Thank you for submitting your report
We will investigate and take the appropriate action.
FIRST RFID CHIP (HIPRA) IN ANIMAL VACCINES (IN THE WORLD) - HIPRA COVID VAX AUTHORIZED, RFID CHIP?
https://odysee.com/@EnriquePascual:7/Hipra_smart_vaccination:6
SPANISH GOVERNMENT AUTHORIZES THIS COMPANY (HIPRA) DEVELOPS A COVID VACCINE FOR HUMANS, RFID CHIP TOO??. Video-implanting the RFID chip in pigs 👉 https://www.youtube.com/watch?v=zbPj3Dmlf3A
AEMPS authorizes the first clinical trial of a Spanish vaccine, PHH-1V of HIPRA against COVID-19 (WITH CHIP RFID ALSO ??).
www.aemps.gob.es/informa/notasinformativas/laaemps/2021-2/la-aemps-autoriza-el-primer-ensayo-clinico-de-una-vacuna-espanola-frente-a-la-covid-19/?fbclid=IwAR1J2n2UePLRE3xP1jF68oOh5iMuX7W4KMyP3zJ6XhLwi6ldAcBGfdP2Cqw
VACCINE PHH-1V - VETERINARY PHARMACEUTICAL HIPRA.
-The main objective of the phase I / IIa trial of Hipra laboratories is to evaluate the safety and tolerability of the PHH-1V vaccine. Additionally, its immunogenicity and efficacy will be evaluated.
-Several dozen volunteers between the ages of 18 and 39 will participate, who will receive two doses of the vaccine
-This vaccine is based on two recombinant proteins (a platform similar to that of Novavax and Sanofi / GSK) capable of generating an immune response against one of the SARS_CoV_2 proteins
-This type of trial is essential to guarantee the quality, safety and efficacy of vaccines. This milestone represents a step forward in obtaining scientific evidence for this vaccine in humans.............................................................................................................................................................................................................................................................................
This vaccine is based on two structurally similar recombinant proteins, one corresponding to the alpha variant and the other corresponding to the beta variant, which come together to form a unique structure called a dimer, and which are accompanied by an adjuvant that increases the immune response. This combination is capable of generating an immune response against one of the proteins of the SARS-CoV-2 virus, known as protein S (from spike, also called spike protein in Spanish). This platform is the same as that used for the Novavax and Sanofi / GSK vaccines, which are already in the process of being evaluated for their potential authorization by the European Medicines Agency (EMA), but to Unlike them, it expresses proteins of two different variants.
In the study, the volunteers will be divided into groups (cohorts) and the lowest dose will be administered to the first cohort.
CORPORATE HIPRA VIDEO www.youtube.com/watch?v=LG9COAGSYX0
HIPRA ia a veterinary pharmaceutical company dedicated to the research, production and commercialization of products for ANIMAL HEALTH. Provides vaccines (INJECTABLE SOLUTIONS FOR SWINE, BOVINE AND SHEEP), vaccination devices, diagnostic kits and pharmaceutical products. In addition, the company offers training programs in the field of disease prevention, online tools, and a mobile application to support veterinarians.
www.hipracovid19.com/
www.hipracovid19.com/wp-content/uploads/2021/04/210415-400-millones-dosis-vacuna-HIPRA-SARS-CoV-2-durante-2022-ES.pdf
HIPRA plans to produce 400.000.000 doses of its vaccine HIPRA SARS-CoV-2 during 2022
The recombinant protein vaccine developed by HIPRA will initiate the phase of clinical trials in June and would begin to take place in October 2021
www.hipra.com/portal/es/hipra/animalhealth/species/poultry
With INTELLIGENT VACCINATION tools:
HIPRAlink® Vaccination
Application for veterinarians developed by HIPRA to allow the traceability of vaccination processes for Animal Health.
HIPRAlink® Vaccination stands for Planning, Control and Analysis
HIPRAlink® Vaccination is the application developed by HIPRA that records all the vaccination data generated by the Smart Devices (Hipradermic®, Hipraspray® and Hipraject®) and offers traceability to the entire vaccination process. It helps veterinarians and hatchery managers to manage, monitor and analyze their own vaccination activity.
HYPRA SMART VACCINATION youtube.com/watch?v=EsdJWqYKhVQ
TOTAL TRACEABILITY, FIRST COMPANY TO INTRODUCE RFID CHIP IN ITS VACCINES FOR ANIMALS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!! see video www.hipra.com/portal/es/hipra/animalhealth/services/detail/hipralink-vaccination
They use a platform similar to that of the criminals Sanofi / GSK and ONE ADJUVANT, I DON'T KNOW WHICH
GSK specialist in adjuvants for vaccines such as AS04, SAL DE ALUMINIO (ALUMBRE) !!!!!!!!!!!!!!!!!!!!, and that already in February 2020 had an agreement with the criminal CEPI for "Chinese" coronavirus ................... www.fiercebiotech.com/biotech/gsk-makes-adjuvant-available-to-coronavirus-vaccine-project
Category | None |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
Playing Next
Related Videos
2 years, 7 months ago
MIKE OLDFIELD - TO FRANCE (OFFICIAL VIDEO)
2 years, 7 months ago
DARK VADER19 - DEATH STAR CANTEEN
2 years, 8 months ago
Warning - This video exceeds your sensitivity preference!
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.